{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:56:16Z","timestamp":1760100976908,"version":"3.41.0"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AR"],"published-print":{"date-parts":[[2017,4,1]]},"DOI":"10.21873\/anticanres.11539","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T07:01:04Z","timestamp":1491289264000},"page":"1975-1978","source":"Crossref","is-referenced-by-count":5,"title":["Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples"],"prefix":"10.21873","volume":"37","member":"9336","container-title":["Anticancer Research"],"original-title":[],"link":[{"URL":"http:\/\/ar.iiarjournals.org\/content\/37\/4\/1975.full.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:50:56Z","timestamp":1524019856000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/content\/37\/4\/1975.abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.21873\/anticanres.11539","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"type":"print","value":"0250-7005"},{"type":"electronic","value":"1791-7530"}],"subject":[],"published":{"date-parts":[[2017,4,1]]}}}